158 filings
10-Q
2024 Q1
DNLI
Denali Therapeutics Inc
Quarterly report
7 May 24
4:05pm
8-K
DNLI
Denali Therapeutics Inc
7 May 24
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
4:03pm
ARS
2023 FY
DNLI
Denali Therapeutics Inc
18 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
DNLI
Denali Therapeutics Inc
18 Apr 24
Additional proxy soliciting materials
4:04pm
DEF 14A
DNLI
Denali Therapeutics Inc
Definitive proxy
18 Apr 24
4:03pm
S-3ASR
0dddu 8abdofv
22 Mar 24
Automatic shelf registration
4:01pm
D
s3j 2ow0ijw
1 Mar 24
$499.73 mm in equity / options, sold $499.73 mm, 11 investors
4:51pm
S-8
zbw64
27 Feb 24
Registration of securities for employees
8:21pm
8-K
3js4sezl
27 Feb 24
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
8:07am
8-K
dg2gt
27 Feb 24
Denali Therapeutics Announces $500 million Private Placement Equity Financing
8:03am
8-K
jmqqpz q454
16 Feb 24
Regulation FD Disclosure
8:02am
8-K
363k752nya6j
8 Jan 24
Regulation FD Disclosure
8:06am
8-K
med9yrz1
7 Nov 23
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
zr5sc9kn2wdhx8vk zt6
21 Aug 23
Entry into a Material Definitive Agreement
4:06pm
8-K
pr5 urqi3pku0baeck
8 Aug 23
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
rrunlem8fkmjdcrn7q34
20 Jun 23
Other Events
7:03am
8-K
echwaayf4ag1r
5 Jun 23
Other Events
8:12am